BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9241369)

  • 1. New cytostatic agents for the treatment of head and neck cancer.
    Devriendt D; Klastersky J
    Acta Otorhinolaryngol Belg; 1997; 51(2):61-8. PubMed ID: 9241369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the taxoids and other new agents in head and neck cancer therapy.
    Schrijvers D; Vermorken JB
    Curr Opin Oncol; 1998 May; 10(3):233-41. PubMed ID: 9619360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Docetaxel].
    Takigawa N
    Nihon Rinsho; 2002 May; 60 Suppl 5():349-52. PubMed ID: 12101686
    [No Abstract]   [Full Text] [Related]  

  • 4. Current and future perspectives in advanced bladder cancer: is there a new standard?
    von der Maase H
    Semin Oncol; 2002 Feb; 29(1 Suppl 3):3-14. PubMed ID: 11894002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phase III clinical trials concerning non-small-cell lung carcinoma (NSCLC) presented at the ASCO 2001].
    Morere JF
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S37-41. PubMed ID: 11924242
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined systemic therapy and radiotherapy for bladder cancer.
    Rödel C; Weiss C; Sauer R
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():29-31. PubMed ID: 18167005
    [No Abstract]   [Full Text] [Related]  

  • 7. [Concomitant radiochemotherapy for non-small-cell lung cancer: towards an ideal strategy].
    Rixe O
    Rev Mal Respir; 2001 Sep; 18(4 Pt 1):365-6. PubMed ID: 11547240
    [No Abstract]   [Full Text] [Related]  

  • 8. [Palliative chemotherapy of head and neck cancer: present status and future development].
    Hennemann B
    Laryngorhinootologie; 2006 Mar; 85(3):172-8. PubMed ID: 16547892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy in head and neck cancer. Overview of newer agents.
    Khattab J; Urba SG
    Hematol Oncol Clin North Am; 1999 Aug; 13(4):753-68. PubMed ID: 10494511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract.
    Dodd PM; McCaffrey JA; Hilton S; Mazumdar M; Herr H; Kelly WK; Icasiano E; Boyle MG; Bajorin DF
    J Clin Oncol; 2000 Feb; 18(4):840-6. PubMed ID: 10673526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preclinical model for experimental chemotherapy of human head and neck cancer.
    Sommer K; Peters SO; Robins IH; Raap M; Wiedemann GJ; Remmert S; Sieg P; Bittner C; Feyerabend T
    Int J Oncol; 2001 Jun; 18(6):1145-9. PubMed ID: 11351243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine-based combination treatment of pancreatic cancer.
    Heinemann V
    Semin Oncol; 2002 Feb; 29(1 Suppl 3):25-35. PubMed ID: 11894005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Second-line and beyond: Docetaxel in the treatment of non-small-cell lung cancer].
    Rinaldi M
    Tumori; 2001; 87(6):A6-9. PubMed ID: 11995708
    [No Abstract]   [Full Text] [Related]  

  • 14. [New therapeutic approaches in non-small-cell lung carcinoma (NSCLC), stages IV].
    Mavroudis D
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S42-5. PubMed ID: 11924243
    [No Abstract]   [Full Text] [Related]  

  • 15. Future directions in the chemotherapy of ovarian cancer.
    Ozols RF
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-86-S15-90. PubMed ID: 9346230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non--small cell lung cancer.
    Hainsworth JD; Burris HA; Greco FA
    Semin Oncol; 2001 Jun; 28(3 Suppl 9):21-5. PubMed ID: 11441411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternating chemotherapy: gemcitabine and cisplatin with concurrent radiotherapy for treatment of advanced head and neck cancer.
    Aguilar-Ponce JL; Granados-García M; Cruz López JC; Maldonado-Magos F; Alvarez-Avitia MA; Arrieta O; González-Ramírez I; Lara-Cruz G; Martinez-Juárez I; Medina-Santillan R; Castillo-Hernández C; De la Garza-Salazar J
    Oral Oncol; 2013 Mar; 49(3):249-54. PubMed ID: 23043985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experience.
    O'Shaughnessy J
    Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):15-21. PubMed ID: 14768400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy of stage IV non-small-cell lung cancer: contribution of gemcitabine].
    Souquet PJ; Gérinière L
    Rev Pneumol Clin; 2000 Nov; 56(5):315-9. PubMed ID: 11139761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoradiation in locally advanced non-small cell lung cancer.
    Bonomi P; Shirazi W
    Cancer Treat Res; 2001; 105():171-88. PubMed ID: 11224987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.